Dotbee.ai

Analysis Mehta Housing Finance Limited (MEHTAHG)

5/30/2024

Analysis Mehta Housing Finance Limited (MEHTAHG)

Analysis of Mehta Housing Finance Limited (MEHTAHG)

Mehta Housing Finance Limited (MEHTAHG) has shown a consistent uptrend in its stock price over the past few days. The Relative Strength Index (RSI) values have been consistently high, indicating that the stock may be overbought. However, the Moving Average Convergence Divergence (MACD) indicator suggests a bullish trend, with the MACD line consistently above the signal line.

The stock price has been trading above the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, indicating a positive momentum. The stock has been making higher highs and higher lows, which is a bullish sign.

Overall, based on the technical indicators, Mehta Housing Finance Limited seems to be in a strong bullish trend. However, investors should keep an eye on the RSI values to watch for potential overbought conditions.

Earnings

The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.

In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.

Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.

Valuation metrics show a relatively high PEG ratio and forward PE ratio, with the company's market capitalization and enterprise value also provided. The price to book and price to sales ratios are on the higher side, while the enterprise to EBITDA and enterprise to revenue ratios are moderate.

The stock price summary includes beta, moving averages, and the range of prices over the past year.

Lastly, dividends and splits information shows the company's dividend dates, split history, and dividend yield metrics.

Income statement 💸

These are the revenues. Here are the conclusions:

1. The company's sales have been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased from $3.28 in 2020 to $6.16 in 2023.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
7. Despite an increase in income tax expenses, the company has managed to grow its net income continuously.
8. The company has been effectively managing its operating expenses, with a slight increase in research and development costs over the years.
9. Non-operating interest expenses have been relatively stable, indicating a consistent financial management approach.
10. The number of basic and diluted shares outstanding has remained stable over the years.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist of investments, machinery, and other assets, with investments and advances being a significant portion.
4. Total liabilities have also been increasing, with the highest value of $302,083,000,000 in 2022.
5. Current liabilities include short-term debt, accounts payable, and other current liabilities.
6. Non-current liabilities comprise long-term debt and other non-current liabilities.
7. Shareholders' equity has shown variations, with the highest value of $90,488,000,000 in 2019.
8. Common stock and retained earnings are part of shareholders' equity.
9. The company has been investing in leases, land, and improvements over the years.
10. Accumulated depreciation has been increasing, indicating the aging of assets.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been consistently higher than free cash flow, indicating that the company is generating sufficient cash from its core operations.
3. The company has been paying a significant amount in income taxes each year, with the highest amount paid in 2021.
4. The company has been consistently paying interest on its debts each year.
5. The end cash position has also been fluctuating, with the highest position in 2020 and the lowest in 2022.
6. The company has been actively involved in financing activities, including common stock repurchases, debt issuances, and dividend payments.
7. Investing activities have also been significant, with the company making acquisitions, capital expenditures, and investments.
8. Overall, the company's cash flow statement reflects a mix of operational, financing, and investing activities that impact its cash position and financial health.

Earnings estimate

Based on the analysts' estimates for future quarterly and annual earnings per share:

1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a range from $1.27 to $1.36. This shows an improvement compared to the EPS of $1.26 from the same quarter a year ago.

2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a range from $1.44 to $1.63. This is slightly higher than the EPS of $1.46 from the same quarter last year.

3. Looking at the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.59, with a range from $6.43 to $6.92. This indicates growth from the EPS of $6.13 in the previous fiscal year.

4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $7.23, with a range from $6.40 to $7.90. This forecast suggests an increase from the EPS of $6.59 in the current fiscal year.

Overall, the analysts are predicting growth in earnings per share for both the upcoming quarters and the full fiscal years, indicating positive expectations for the company's performance.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, the following conclusions can be drawn:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.

These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.

Growth estimates

Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:

1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.

These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience solid growth both in the short and long term according to analyst consensus.

Price target

The analysts' forecast for the future price of the security paper is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential opportunity for growth according to the analysts' predictions.

MACD of MEHTAHG

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link